India Home Healthcare Market

India Home Healthcare Market Analysis

The India Home Healthcare Market size is estimated at USD 11.90 billion in 2025, and is expected to reach USD 27.38 billion by 2030, at a CAGR of 18.13% during the forecast period (2025-2030).

The home healthcare market is witnessing significant growth, driven by factors such as rising disposable incomes, an aging population, increasing prevalence of chronic diseases, and advancements in technology. The demand for home healthcare services is further fueled by the need for better primary and postoperative care, particularly among the elderly. The key market players are leveraging strategic initiatives to expand their presence and address the growing healthcare needs.

Rising disposable incomes, an increase in surgical procedures, a growing geriatric population, and advancements in technology are driving the home healthcare market. The rising prevalence of chronic diseases among the elderly, coupled with the need for improved primary and postoperative care, is expected to propel the home care services market. For instance, in 2023, the Indian Council of Medical Research (ICMR) projected that India is expected to have 81,219 new lung cancer diagnoses by 2025. The anticipated increase in cancer cases requiring long-term care is likely to drive market growth during the forecast period.

The aging population, driven by declining birth rates and increasing life expectancy, is contributing to a higher prevalence of chronic diseases, thereby creating a robust demand for home healthcare services and software. According to the India Ageing Report 2023, the population aged 60 years and above in India is projected to double from 149 million in 2022 to 347 million by 2050. This growing elderly demographic, which is more susceptible to chronic diseases such cardiovascular, orthopedic, and diabetes, is expected to significantly boost the market's growth over the forecast period. The rapid aging of the population, coupled with their increased vulnerability to chronic diseases, is anticipated to further accelerate the demand for home healthcare products and services, driving market expansion.

Market players are actively expanding their presence across India by adopting advanced technologies and engaging in strategic collaborations, mergers, and acquisitions. For instance, in April 2023, OMRON Healthcare Co. Ltd. entered the remote home heart monitoring and management segment through a collaboration with Tricog, a leading AI company specializing in heart disease diagnosis and management in the Indian market. Additionally, in August 2023, Glenmark Pharmaceuticals Limited partnered with OMRON Healthcare India, the Indian subsidiary of the Japanese leader in home blood pressure monitoring and cardiovascular disease management solutions, to promote awareness about home blood pressure monitoring starting from the age of 18. These initiatives reflect the commitment of key players to enhance their offerings and address the growing demand for home healthcare solutions.

In conclusion, the increasing burden of chronic diseases, the expanding geriatric population, and the strategic initiatives undertaken by market players are expected to drive significant growth in the home healthcare market over the forecast period. However, challenges such as limited awareness and a shortage of skilled professionals may act as restraints to market expansion. Companies that continue to innovate and invest in strategic partnerships are well-positioned to capitalize on the growing opportunities in this market.

India Home Healthcare Market Trends

Diagnostics Segment is Expected to Witness a Significant Growth Over the Forecast Period

Home health diagnostics represent a diverse portfolio of services and products designed to facilitate disease diagnosis within the home setting. These products are typically cost-effective and offer enhanced convenience. The diagnostics segment is projected to witness substantial growth, driven by the increasing prevalence of chronic diseases and the introduction of innovative products by industry stakeholders.

The diagnostics segment is anticipated to generate the highest revenue during the forecast period, primarily due to the rising incidence of chronic conditions such as infectious diseases, diabetes, arthritis, and cardiovascular disorders, which require ongoing monitoring for effective management. For instance, according to the International Diabetes Federation estimates that diabetes cases in India will reach 92.97 million by 2030 and 124.2 million by 2045. This significant burden of chronic diseases, including diabetes and hypertension, is expected to drive demand for home-based diagnostic solutions, thereby contributing to market expansion.

Furthermore, strategic initiatives by market participants, such as product launches, mergers, acquisitions, and partnerships, are expected to enhance product availability and market penetration, supporting segment growth. For example, in December 2023, Arva Health, an India-based start-up, launched an at-home fertility test tailored for Indian women managing polycystic ovary syndrome (PCOS) and thyroid-related issues. This product enables women to monitor their hormonal health effectively, facilitating early detection of fertility challenges and empowering them to take proactive steps in managing their reproductive health.

In conclusion, the combination of rising chronic disease prevalence, increasing demand for home-based diagnostic solutions, and strategic efforts by market players to expand their product offerings and market reach is expected to drive robust growth in the home health diagnostics market over the forecast period.

Respiratory Therapy Services Segment is Expected to Hold a Significant Share Over the Forecast Period

Respiratory diseases include conditions that affect the lungs and the respiratory system. These diseases can result from infections, tobacco consumption, exposure to second-hand smoke, or inhalation of pollutants such as radon, asbestos, and other airborne contaminants. The respiratory products segment is experiencing growth, driven by the increasing prevalence of respiratory disorders and strategic initiatives by market players, including a rise in product approvals and market expansion efforts.

The rising incidence of respiratory diseases is driving demand for respiratory therapy services, thereby contributing to market growth. For example, an October 2024 report by the World Health Organization highlighted that India recorded a TB incidence rate of 195 cases per 100,000 individuals in 2023. Additionally, a June 2024 article in Cureaus Journal reported that the annual incidence rate of community-acquired pneumonia (CAP) in India ranges between five to 11 cases per 1,000 people. The growing prevalence of respiratory conditions such as TB and asthma is expected to drive market growth during the forecast period.

Furthermore, strategic initiatives by both government and private entities to enhance respiratory care services are anticipated to support market expansion. For instance, in October 2024, Aerogen signed a Memorandum of Understanding (MoU) with the Indian Association of Respiratory Care (IARC). This partnership aims to advance respiratory therapy education and improve patient care across India, representing a significant step toward strengthening respiratory care services in the region.

Market players are actively pursuing strategic collaborations, partnerships, and mergers to drive growth. For example, in March 2023, Apollo Hospitals partnered with LifeSigns to donate 1,000 remote patient monitoring patches. These patches are designed for use in settings requiring close monitoring of vital signs, including cardiac rhythm, ECG rhythm, and respiratory rate.

In conclusion, the increasing burden of respiratory diseases, coupled with the expansion of respiratory care services and strategic initiatives by key stakeholders, is expected to significantly drive the growth of the respiratory products segment over the forecast period.

India Home Healthcare Industry Overview

The India home healthcare market is fragmented and consists of several major players. Some of the companies are expanding their market position by adopting various strategies, such as mergers and acquisitions, and research collaborations with other companies to launch innovative products and consolidate their market positions in India. Some of the key market players are B. Braun SE, Fresenius SE & Co KGaA, Medline Industries, Inc., Portea Medical, India Home Health Care among others.

India Home Healthcare Market Leaders

India Home Healthcare Market News

• July 2024: Indiana Hospital and Heart Institute partnered with Critical Care Unified (CCU), a home healthcare provider, to roll out home care services. These services will cater to the region, including northern Kerala. The offerings will feature ICU-at-home, specialized care for cancer, cardiac conditions, and strokes, as well as oxygen and medical equipment supply, Covid-19 testing, and additional healthcare solutions.
• July 2024: Star Health and Allied Insurance introduced its Home Health Care services, designed to provide healthcare solutions directly at customers' doorsteps.